Wendyl J. D’sOuza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wendyl J. D’sOuza has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mark James Cook
University of Melbourne
3 shared publications - Neil Pearce
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
2 shared publications - Stephen Quinn
Department of Health Science and Biostatistics, Swinburne University of Technology, Melbourne, Australia
2 shared publications B. V. Taylor
The Menzies Research Institute, The University of Tasmania, Hobart, Tasmania
1 shared publicationBruce V. Taylor
1 shared publicationD. M. Ficker
The University of Cincinnati Academic Health Centre, Department of Neurology, Cincinnati, OH, USA
1 shared publication
Latest Publications
- 1 March 2011
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 125 (2) , 96-104
The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia
D’Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, O’Brien TJ, Pearce N, Cook MJ. The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia. Acta Neurol Scand: 2012: 125: 96–104. © 2011 John Wiley & Sons A/S. Objectives – To estimate the prevalence and demographic distribution of treated epilepsy in a community-based population. Materials & methods – We surveyed all residents in Tasmania, Australia, who were supplied at least one antiepileptic drug prescription between July 1, 2001 and June 30, 2002, recorded on the national prescription database. We adjusted for the effect of disease-related non-response bias by imputation methods. Results – After three mail contacts, 54.0% (4072/7541) responded, with 1774 (43.6%) indicating treatment for epilepsy, representing 86.0% of the estimated total possible cases in Tasmania. The adjusted treated epilepsy prevalence was 4.36 per 1000 (95% CI 4.34, 4.39); lower in women (prevalence ratio 0.92 (95% CI 0.84, 1.00)); greater with increasing age (P < 0.001); similar in the three main geographic regions; and similar with socioeconomic status of postcode of residence. Conclusions – Although our estimates are likely to be affected by access to health services, overall treated epilepsy prevalence of 4.4 per 1000 is similar to previous studies. Our finding of high elderly prevalence has been reported in a few recent studies in developed countries and has important clinical and public health implications in populations with similar aging demographics.
- 1 March 2011
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 125 (2) , 96-104
The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia
D’Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, O’Brien TJ, Pearce N, Cook MJ. The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia. Acta Neurol Scand: 2012: 125: 96–104. © 2011 John Wiley & Sons A/S. Objectives – To estimate the prevalence and demographic distribution of treated epilepsy in a community-based population. Materials & methods – We surveyed all residents in Tasmania, Australia, who were supplied at least one antiepileptic drug prescription between July 1, 2001 and June 30, 2002, recorded on the national prescription database. We adjusted for the effect of disease-related non-response bias by imputation methods. Results – After three mail contacts, 54.0% (4072/7541) responded, with 1774 (43.6%) indicating treatment for epilepsy, representing 86.0% of the estimated total possible cases in Tasmania. The adjusted treated epilepsy prevalence was 4.36 per 1000 (95% CI 4.34, 4.39); lower in women (prevalence ratio 0.92 (95% CI 0.84, 1.00)); greater with increasing age (P < 0.001); similar in the three main geographic regions; and similar with socioeconomic status of postcode of residence. Conclusions – Although our estimates are likely to be affected by access to health services, overall treated epilepsy prevalence of 4.4 per 1000 is similar to previous studies. Our finding of high elderly prevalence has been reported in a few recent studies in developed countries and has important clinical and public health implications in populations with similar aging demographics.
- 6 March 2007
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (10) , 769-771
Toothbrushing-induced epilepsy with structural lesions in the primary somatosensory area
We report three patients with reflex toothbrushing-induced epilepsy associated with small circumscribed structural lesions in the primary somatosensory cortex in close proximity to the hand and speech motor areas. Sensory symptoms were observed at clinical onset with localizing focal ictal and interictal epileptiform discharges on EEG. These cases refine the localization, possible mechanisms of epileptogenesis, and classification of this reflex epilepsy.
- 6 March 2007
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (10) , 769-771
Toothbrushing-induced epilepsy with structural lesions in the primary somatosensory area
We report three patients with reflex toothbrushing-induced epilepsy associated with small circumscribed structural lesions in the primary somatosensory cortex in close proximity to the hand and speech motor areas. Sensory symptoms were observed at clinical onset with localizing focal ictal and interictal epileptiform discharges on EEG. These cases refine the localization, possible mechanisms of epileptogenesis, and classification of this reflex epilepsy.
- 1 January 2007
- Published by S. Karger AG in Neuroepidemiology
- Vol. 29 (3-4) , 255-263
The Tasmanian Epilepsy Register – A Community-Based Cohort
Background/Aims: Centralized prescription databases may provide an efficient mechanism for recruitment of community-treated disease. Methods: The Australian federal government agency, the Health Insurance Commission (HIC), invited patients to participate in the Tasmanian Epilepsy Register (TER). Eligible patients included those who received at least one anticonvulsant above a ‘reportable’ price threshold between July 1, 2001 and June 30, 2002. Patients were asked to disclose their medical indication for anticonvulsant treatment with additional demographic and prescription information obtained from the HIC. Results: 7,541 were eligible for recruitment. After two mail invitations over 6 months, 3,375 (46.6%) had responded, but TER enrollment amongst those indicating treatment for epilepsy was 1,180 (78.3%). TER participants were more likely to obtain their prescriptions exclusively from their general practitioner (70.9%) or from combined sources (19.1%) rather than from pediatrician (4.2%), neurologist (1.4%) or general physician (1.0%) sources. Patients were more likely to respond with increasing age (linear trend p < 0.001), when from a higher socioeconomic area (linear trend p < 0.001), or if their prescription was obtained from a neurologist (p < 0.001). Conclusion: The national Australian prescription database represents community-treated epilepsy and provides an effective and efficient method for patient recruitment for clinical epidemiological research.
- 1 January 2007
- Published by S. Karger AG in Neuroepidemiology
- Vol. 29 (3-4) , 255-263
The Tasmanian Epilepsy Register – A Community-Based Cohort
Background/Aims: Centralized prescription databases may provide an efficient mechanism for recruitment of community-treated disease. Methods: The Australian federal government agency, the Health Insurance Commission (HIC), invited patients to participate in the Tasmanian Epilepsy Register (TER). Eligible patients included those who received at least one anticonvulsant above a ‘reportable’ price threshold between July 1, 2001 and June 30, 2002. Patients were asked to disclose their medical indication for anticonvulsant treatment with additional demographic and prescription information obtained from the HIC. Results: 7,541 were eligible for recruitment. After two mail invitations over 6 months, 3,375 (46.6%) had responded, but TER enrollment amongst those indicating treatment for epilepsy was 1,180 (78.3%). TER participants were more likely to obtain their prescriptions exclusively from their general practitioner (70.9%) or from combined sources (19.1%) rather than from pediatrician (4.2%), neurologist (1.4%) or general physician (1.0%) sources. Patients were more likely to respond with increasing age (linear trend p < 0.001), when from a higher socioeconomic area (linear trend p < 0.001), or if their prescription was obtained from a neurologist (p < 0.001). Conclusion: The national Australian prescription database represents community-treated epilepsy and provides an effective and efficient method for patient recruitment for clinical epidemiological research.